Skip to main content

Main menu

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Reprint Information
    • Feedback
    • Email Alerts
  • ASN Kidney News
  • Other
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology

User menu

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Reprint Information
    • Feedback
    • Email Alerts
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow Kidney360 on Twitter
  • Community Forum
  • Kidney360 RSS

Chronic Kidney Disease

  • Patiromer and spironolactone in resistant hypertension and advanced CKD: analysis of the randomized AMBER trial
    Rajiv Agarwal, Patrick Rossignol, Jeffrey Budden, Martha R. Mayo, Susan Arthur, Bryan Williams and William B. White
    Kidney360 January 2021, 10.34067/KID.0006782020; DOI: https://doi.org/10.34067/KID.0006782020
    Add to Selected Citations
  • <em>APOL1</em> Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis
    APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis
    Lijun Ma, Nicholette D. Palmer, Young A Choi, Mariana Murea, James A. Snipes, John S. Parks, Carl D. Langefeld and Barry I. Freedman
    Kidney360 December 2020, 1 (12) 1353-1362; DOI: https://doi.org/10.34067/KID.0003592020
    Add to Selected Citations
  • Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial
    Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial
    David M. Charytan, Jesse Y. Hsu, Finnian R. Mc Causland, Sushrut S. Waikar, T. Alp Ikizler, Dominic S. Raj, J. Richard Landis, Rajnish Mehrotra, Mark Williams, Marcelo DiCarli, Hicham Skali, Paul L. Kimmel, Alan S. Kliger, Laura M. Dember, for the Hemodialysis Novel Therapies Consortium, Hemodialysis Novel Therapies Consortium, Jonathan Himmelfarb, Amanda H Anderson, Adriana M Hung, Shailendra Sharma and Daniel E. Weiner
    Kidney360 December 2020, 1 (12) 1380-1389; DOI: https://doi.org/10.34067/KID.0004342020
    Add to Selected Citations
  • Global Dialysis Perspective: South Africa
    Thabiet Jardine and Mogamat Razeen Davids
    Kidney360 December 2020, 1 (12) 1432-1436; DOI: https://doi.org/10.34067/KID.0005152020
    Add to Selected Citations
  • Severe Hypertension in a 3-Month-Old Infant
    Jonathan Chawla, David Manning and Isa Ashoor
    Kidney360 December 2020, 1 (12) 1464-1465; DOI: https://doi.org/10.34067/KID.0003602020
    Add to Selected Citations
  • The impact of chronic kidney disease on perioperative risk and mortality after bariatric surgery
    Flavia Carvalho Silveira, William P. Martin, Gabrielle Maranga, Carel W. le Roux and Christine J. Ren-Fielding
    Kidney360 December 2020, 10.34067/KID.0004832020; DOI: https://doi.org/10.34067/KID.0004832020
    Add to Selected Citations
  • Resident macrophages in cystic kidney disease
    Zhang Li, Kurt A. Zimmerman and Bradley K. Yoder
    Kidney360 December 2020, 10.34067/KID.0006052020; DOI: https://doi.org/10.34067/KID.0006052020
    Add to Selected Citations
  • Overview of The Human Heredity and Health in Africa Kidney Disease Research Network (H3A-KDRN)
    Dwomoa Adu and Akinlolu Ojo
    Kidney360 December 2020, 10.34067/KID.0002592020; DOI: https://doi.org/10.34067/KID.0002592020
    Add to Selected Citations
  • Group II GBCM can be used safely for imaging in stage 4/5 CKD patients: CON
    Patrick H. Pun and Susan T. Crowley
    Kidney360 December 2020, 10.34067/KID.0005572020; DOI: https://doi.org/10.34067/KID.0005572020
    Add to Selected Citations
  • SARS-CoV-2 in spent dialysate from chronic peritoneal dialysis patients with COVID-19
    Xiaoling Wang, Amrish Patel, Lela Tisdale, Zahin Haq, Xiaoling Ye, Rachel Lasky, Priscila Preciado, Xia Tao, Gabriela Ferreira Dias, Joshua E. Chao, Mohamad Hakim, Maggie Han, Ohnmar Thwin, Jochen Raimann, Dinesh Chatoth, Peter Kotanko and Nadja Grobe
    Kidney360 December 2020, 10.34067/KID.0006102020; DOI: https://doi.org/10.34067/KID.0006102020
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • Kidney360
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About Kidney360
  • Kidney360 Email Alerts
  • Kidney360 Podcasts
  • Kidney360 RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Disqus Code of Conduct
  • Disqus Information
  • Feedback
  • Follow on Twitter
  • Subscribe to JASN and CJASN

© 2021 American Society of Nephrology

Online ISSN - 2641-7650

Powered by HighWire